The largest database of trusted experimental protocols

Bright glo luciferase assay buffer

Manufactured by Promega
Sourced in United States, France, Poland

The Bright-Glo™ Luciferase Assay Buffer is a reagent designed for the detection and quantification of luciferase activity in biological samples. It provides a stable luminescent signal that can be used to measure the expression of reporter genes in cell-based assays.

Automatically generated - may contain errors

4 protocols using bright glo luciferase assay buffer

1

Near-IR Spectral Analysis of Luciferase Substrates

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 10

For spectral analysis of PBI-4739 and PBI-4813, ATP was added to a concentration of 1 mM to Bright-Glo™ Luciferase Assay Buffer (Promega Corporation Cat. No. E264A). PBI-4739 and PBI-4813 (100 mM DMSO stock) was diluted to 1:100 into Bright-Glo™ Luciferase Assay Buffer (1 mM final). 50 ul of each substrate was added to 50 ul of Click Beetle Red purified enzyme (0.5 mg/ml; Promega Corporation) in triplicate and then the samples assayed using a Tecan M-1000 in spectral scan mode using 2 nm steps for 4739 and 5 nm steps for 4813.

FIG. 14 provides the spectral data for the two substrates demonstrating their near-IR properties.

+ Open protocol
+ Expand
2

Luciferase Assay for NF-κB, NFAT, and AP-1 Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reporter cells (RAW-NF-κB-Luc, RAW-NFAT-Luc, and RAW-AP-1-Luc) were cultured in DMEM medium (GE Healthcare, USA) supplemented with 10% fetal bovine serum (FBS, Thermo Fisher Scientific, USA), 50 U/mL penicillin, 50 μg/mL streptomycin, 2 mM glutamine, and 0.1 M NaHCO3 (all PanEco, Russia) at 37°C with 5% CO2. We used the protocol described in our previous work [16 (link)]; namely, experiment cells were seeded at 1 × 105 cells/well in 96-well plates (100 μL/well). The next day, C-type lectin receptor agonists were added to the wells to a final concentration of 20 μg/mL, 4 μg/mL, and 1 μg/mL. Eight hours later, to detect luciferase activity, 100 μL of Bright-Glo Luciferase Assay Buffer containing luciferin substrate (Promega, USA) was added to each well. Luminescence was measured in relative units using a Synergy H4 Hybrid Reader (BioTek, Germany).
+ Open protocol
+ Expand
3

UHRF1 Silencing in Toxoplasma Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The corresponding nucleotides of UHRF1 were cloned into a siRNA expression vector, psiU6BX3, constructed as previously described [30 (link)]. A EGFP-siRNA or UHRF1-siRNA (si-3: 2123–2141) plasmid construct was transfected to cells for 24 h and incubated with 900 µg/ml of G418 for a further 48 h before infection with T. gondii as indicated in the figure legends. Cells were then harvested for Western blotting. pGL3-UHRF1-Luc plasmids were generously donated by M. Unoki, University of Tokyo, Japan. BeWo cells were transfected with plasmids (2 µg/well) for 24 h with X-tremeGENE™ (Sigma-Aldrich, Saint-Quentin-Fallavier, France) transfection reagent and infected with T. gondii for the indicated times and harvested for luciferase activity measurements with 250 µL of Bright-Glo luciferase assay Buffer (Promega, Charbonnières-les-Bains, France). Results are expressed as a ratio of the protein quantification, as our preliminary tests showed that the protein masses of the parasites are negligible compared to the cell protein contents.
+ Open protocol
+ Expand
4

Pseudovirus Production and Transduction

Check if the same lab product or an alternative is used in the 5 most similar protocols
293T cells were seeded on 10-cm-diameter dishes, cultured for 24 h at 37°C with 5% CO2, and transfected using polyethyleneimine (Sigma-Aldrich, Poland) with the lentiviral packaging plasmid (psPAX), the VSV-G envelope plasmid (pMD2G), or SARS-CoV-2 S glycoprotein (pCAGGS-SARS-CoV-2-S) and a third plasmid encoding firefly luciferase protein (pRRL luciferase). Cells were further cultured for 72 h at 37°C with 5% CO2, and pseudoviruses were collected every 24 h and stored at 4°C.
A549ACE2+ cells were seeded in 48-well plates, cultured for 24 h at 37°C with 5% CO2, and transduced with pseudoviruses harboring VSV-G or S-SARS-CoV-2 proteins or lacking the fusion protein (ΔEnv) in the presence of Polybrene (Sigma-Aldrich, Poland) (4 μg/ml) and HTCC-77 (100 μg/ml) or control PBS. After 4 h of incubation at 37°C, unbound virions were removed by three washes with 1× PBS, and cells were further cultured for 72 h at 37°C with 5% CO2. Cells were lysed in Bright-Glo luciferase assay buffer (Promega, Poland) and transferred onto white 96-well plates. Luminescence levels were measured on a Gemini EM microplate reader (Molecular Devices, United Kingdom).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!